Answers are grounded in this paper and cite their sources.
cardiovascular disease (CVD) is a widespread global health issue with significant impacts on health and finances. Dietary factors play a crucial role in CVD risk alongside other factors like hypertension, dyslipidemia, and lifestyle habits such as smoking and physical inactivity. Nutraceuticals, derived from combining "nutrition" and "pharmaceutical," are food components that offer medical benefits including disease prevention and treatment. Research has shown their importance in combating CVD. For example, studies demonstrate the effectiveness of berberine in lowering cholesterol levels, the beneficial effects of Coenzyme Q10 and garlic supplementation on inflammation and endothelial function, and the positive impact of curcumin on metabolic profiles and arterial stiffness. Additionally, Hydroxytyrosol found in olive oil has been linked to reduced inflammation and a lower risk of CVD events. Nutraceuticals show promise in improving therapeutic efficacy and reducing residual risk, particularly for individuals at high risk of diabetes who may not respond well to conventional treatments. While patients generally tolerate nutraceuticals well, long-term safety and efficacy data compared to clinical outcomes are often lacking, indicating a need for further research in this area.
No takes yet. Share an insight, caveat, or question.
A et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: